Cathie Wood's ARK Invest sells Coinbase shares worth $90 million following analyst upgrades
ARK Invest sold nearly half a million Coinbase shares after the crypto exchange earned analyst upgrades for its Q4 outperformance.
Cathie Wood’s investment firm unloaded a total of 499,149 COIN shares from its exchange-traded funds. Specifically, it sold 397,924 shares from its ARK Innovation exchange-traded fund (ARKK), 45,433 shares from its ARK Next Generation Internet ETF (ARKW), and 55,792 shares from its ARK Fintech Innovation ETF (ARKF).
The large sale came after Coinbase received a multitude of analyst upgrades — from the likes of KBW, Wedbush, Canaccord Genuity, and JPM Securities — resulting from better-than-expected fourth-quarter results.
J.P. Morgan analyst Kenneth Worthington was less positive, claiming the firm is “still uncertain of its true earning impact" while acknowledging both strengths and weaknesses. This perspective contrasts with Coinbase’s positive outlook on its participation in the U.S. spot Bitcoin ETF.
Worthington was also critical of the exchange’s lack of clarity around its ETF custodial services.
Meanwhile, the stock price of the crypto exchange saw an increase of nearly 27% last week.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian Dollar remains depressed as firmer USD and trade war counter higher oil prices
Nomura: Hong Kong hedge funds are optimistic about AI but hesitant to increase positions; Anthropic IPO may trigger an AI sell-off in October
After meeting with 45 investors in Hong Kong, Nomura strategist Suda found that this group of investors is generally "exhausted"—although their year-to-date returns remain positive, they have become sidelined after a significant pullback in July. Most investors are cautious in the short term but bullish on AI in the long term, yet are unwilling to increase net buying. The Anthropic IPO could take place as early as October, and the market is concerned that AI stocks may experience a "rise-then-fall" pattern similar to what happened during the SpaceX listing.
Major breakthrough in Moderna(MRNA.US) mRNA cancer vaccine ignites market sentiment! The biotech sector revaluation may have just begun
Moderna's phase 3 clinical trial for melanoma has yielded positive results, serving as a catalyst for the entire biotech sector and driving widespread gains in biotech ETFs. This also reignited market confidence in next-generation therapeutic technologies.

Asia-Pacific stocks under pressure, South Korea leads losses, SK Hynix drops as much as 6%, Bitcoin breaks above $80,000, US Treasuries fluctuate at high levels
Samsung Electronics and SK Hynix both fell by more than 4% and 6% respectively during Monday trading, dragging South Korea's KOSPI index down by over 4% at one point and putting pressure on Asia-Pacific technology stocks. A combination of factors—including Samsung's shareholder return plan falling short of expectations, SK Hynix's labor union rejecting a wage agreement, and Nvidia experiencing its longest losing streak since 2022—have weighed on the market. Investors are now anxiously awaiting this week's Nvidia earnings report and the Jackson Hole meeting.
